1st Counsel – Lifestyle
Author:
Protagenic Therapeutics, Inc.
Protagenic Therapeutics Appoints Industry Veteran Bill Nichols Jr. as President to Accelerate Advancement of First-in-Class TCAP Pathway Therapy PT00114
April 23, 2026
March megadeals anchor global ECM in 1Q26 even as Middle East war spurs uncertainty
March 31, 2026
Protagenic Therapeutics Completes Phytanix Separation, Strengthens Balance Sheet and Repositions the Company Around PT00114
March 17, 2026
Protagenic Therapeutics Upgrades from OTC Pink to OTCQB Venture Market
March 10, 2026